Primary relevance to vitamin D Vitamin D is a stated subject of this paper.
Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.
Why this paper is included
Supporting source evidence:
Analyses by quintiles also revealed no association between the lowest quintile of maternal 25(OH)D levels and schizophrenia (OR 1.09, 95 % CI 0.81 to 1.45, p = 0.55; aOR 1.06, 95 % CI 0.78 to 1.45, p = 0.71).
Source: Abstract. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Study design awaiting verification.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.
Meta-analysis unclear · Blinding unclear / not reported · Research setting awaiting verification
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Maternal vitamin D levels during pregnancy and offspring schizophrenia
Study design awaiting verification · Schizophrenia research · 2024
Original publication title
Maternal vitamin D levels during pregnancy and offspring schizophrenia
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What background does the paper provide?
Findings from previous studies on maternal 25(OH)D levels during pregnancy and offspring schizophrenia are limited and inconsistent.
Source: Background:Abstract: What methods does the paper describe?
We used nationwide population-based register data with a nested case-control design to examine the association between maternal 25(OH)D levels during pregnancy and offspring schizophrenia. The cases of schizophrenia (n = 1145) were born from 1987 to 1997, and received a diagnosis of schizophrenia by 2017, and were matched with equal number of controls. A quantitative immunoassay was used to measure maternal 25 (OH)D in archived maternal serum in the national biobank of the Finnish Maternity Cohort, collected during the first and early second trimesters.
Conditional logistic regression models examined the association between maternal 25(OH)D levels and offspring schizophrenia.
Source: Methods:Abstract: Results
No significant association was found between log-transformed maternal 25(OH)D levels and schizophrenia in unadjusted (OR 0.96, 95 % CI 0.78 to 1.17, p = 0.69) or adjusted analyses (aOR 0.98, 95 % CI 0.79 to 1.22, p = 0.89). Analyses by quintiles also revealed no association between the lowest quintile of maternal 25(OH)D levels and schizophrenia (OR 1.09, 95 % CI 0.81 to 1.45, p = 0.55; aOR 1.06, 95 % CI 0.78 to 1.45, p = 0.71). Maternal 25(OH)D levels, measured in categories, either in deficient category (OR 1.07 (0.85 to 1.35), p = 0.52; aOR 1.05 (0.81 to 1.34), p = 0.88) or insufficient category (OR 1.13, 95 % CI 0.92 to 1.40, p = 0.23; aOR 1.13, 95 % CI 0.90 to 1.41, p = 0.27) were also not associated with offspring schizophrenia.
Source: Results:Abstract: Conclusions
Maternal vitamin D levels in early pregnancy were not associated with offspring schizophrenia. Future studies measuring vitamin D during different stages of gestation are needed to draw firm conclusions.
Source: Conclusions:Authors’ abstract
Background:
Findings from previous studies on maternal 25(OH)D levels during pregnancy and offspring schizophrenia are limited and inconsistent.
Methods:
We used nationwide population-based register data with a nested case-control design to examine the association between maternal 25(OH)D levels during pregnancy and offspring schizophrenia. The cases of schizophrenia (n = 1145) were born from 1987 to 1997, and received a diagnosis of schizophrenia by 2017, and were matched with equal number of controls. A quantitative immunoassay was used to measure maternal 25 (OH)D in archived maternal serum in the national biobank of the Finnish Maternity Cohort, collected during the first and early second trimesters.
Conditional logistic regression models examined the association between maternal 25(OH)D levels and offspring schizophrenia.
Results:
No significant association was found between log-transformed maternal 25(OH)D levels and schizophrenia in unadjusted (OR 0.96, 95 % CI 0.78 to 1.17, p = 0.69) or adjusted analyses (aOR 0.98, 95 % CI 0.79 to 1.22, p = 0.89). Analyses by quintiles also revealed no association between the lowest quintile of maternal 25(OH)D levels and schizophrenia (OR 1.09, 95 % CI 0.81 to 1.45, p = 0.55; aOR 1.06, 95 % CI 0.78 to 1.45, p = 0.71). Maternal 25(OH)D levels, measured in categories, either in deficient category (OR 1.07 (0.85 to 1.35), p = 0.52; aOR 1.05 (0.81 to 1.34), p = 0.88) or insufficient category (OR 1.13, 95 % CI 0.92 to 1.40, p = 0.23; aOR 1.13, 95 % CI 0.90 to 1.41, p = 0.27) were also not associated with offspring schizophrenia.
Conclusions:
Maternal vitamin D levels in early pregnancy were not associated with offspring schizophrenia. Future studies measuring vitamin D during different stages of gestation are needed to draw firm conclusions.
Publication and source details
Original title: Maternal vitamin D levels during pregnancy and offspring schizophrenia
Andre Sourander; Subina Upadhyaya; Heljä-Marja Surcel; Susanna Hinkka-Yli-Salomäki; Keely Cheslack-Postava; Sanju Silwal; Ian W. McKeague; Alan S. Brown
Schizophrenia research · 2024
Shared authorship.
Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T04:09:10.712550+00:00
DOI: 10.1016/j.schres.2024.06.039 · PMC11412259